Literature DB >> 831011

Myocardial revascularization for the patient with drastic impairment of function of the left ventricle.

P Zubiate, J H Kay, A M Mendez.   

Abstract

The results with medical treatment of the patient with coronary artery disease and marked impairment of left ventricular function have been poor. Of 79 patients deemed operable with an ejection fraction of 0.2 or less, only 17 (22 per cent) were alive according to an acturial curve 5 years later. We believed that surgery might offer a better outlook for these critically ill patients. Therefore, since 1969, 140 patients with an injection fraction of 0.2 or less were treated by myocardial revascularization alone, with 31 hospital deaths. Actuarial curve reveals that at 6 years, 59 per cent of the surgically treated patients are alive, and only 22 per cent treated medically are alive at 5 years. It is concluded that if the operative mortality rate is low enough, surgery enhances the survival of patients who have drastic impairment of left ventricular function. These patients are significantly improved clinically.

Entities:  

Mesh:

Year:  1977        PMID: 831011

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  UPDATE ON SURGERY FOR CORONARY ARTERY OCCLUSIVE DISEASE.

Authors:  William E. Bloomer; Myrvin Ellestad
Journal:  Cardiovasc Dis       Date:  1979-06

2.  Is severely left ventricular dysfunction a predictor of early outcomes in patients with coronary artery bypass graft?

Authors:  Seyed Hossein Ahmadi; Abbasali Karimi; Namvar Movahedi; Mahmood Shirzad; Mehrab Marzban; Mokhtar Tazik; Hermineh Aramin; Samaneh Dowlatshahi; Mahmood Sheikh Fathollahi
Journal:  Heart Asia       Date:  2010-07-29

3.  Aortic valve replacement in patients with poor ventricular function-early and late results with long-term follow-up.

Authors:  K Matsui; J H Kay; M Mendez; P Zubiate; N Vanstrom; T Yokoyama; K Tokunaga
Journal:  Jpn J Surg       Date:  1981

4.  Aortocoronary bypass grafting in patients without left main stenosis. Relation of risk factors to early and late survival.

Authors:  H R Phillips; R A Johnson; M A Hindman; G S Wagner; P J Harris; R E Dinsmore; H K Gold; R C Leinbach; A M Hutter; A J Erdmann; W M Daggett; M J Buckley
Journal:  Br Heart J       Date:  1981-05

5.  Myocardial revascularization for patients with an ejection fraction of 0.2 or less. 12 years' results.

Authors:  P Zubiate; J H Kay; E F Dunne
Journal:  West J Med       Date:  1984-05

6.  Preoperative ejection fraction as a predictor of survival after coronary artery bypass grafting: comparison with a matched general population.

Authors:  Mohamed A Soliman Hamad; Albert H M van Straten; Jacques P A M Schönberger; Joost F ter Woorst; Andre M de Wolf; Elisabeth J Martens; André A J van Zundert
Journal:  J Cardiothorac Surg       Date:  2010-04-23       Impact factor: 1.637

7.  Surgical myocardial revascularization of patients with ischemic cardiomyopathy and severe left ventricular disfunction.

Authors:  André L Hovnanian; Alexandre de Matos Soeiro; Carlos Vicente Serrano; Sérgio Almeida de Oliveira; Fábio B Jatene; Noedir A G Stolf; José A F Ramires
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

8.  Non-cardiac surgery in patients with prior myocardial revascularization.

Authors:  P M Cruchley; J A Kaplan; C C Hug; D Nagle; R Sumpter; D Finucane
Journal:  Can Anaesth Soc J       Date:  1983-11

9.  The role of radionuclide angiocardiography in the preoperative prediction of pain relief and prolonged survival following coronary artery bypass grafting.

Authors:  R H Jones; R D Floyd; E H Austin; D C Sabiston
Journal:  Ann Surg       Date:  1983-06       Impact factor: 12.969

10.  Coronary surgery with non-cardioplegic methods in patients with advanced left ventricular dysfunction: immediate and long term results.

Authors:  P E Antunes; J M Ferrão de Oliveira; M J Antunes
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.